Being trans is not a disorder. That is not a political position; it is the settled consensus of international medicine, reflected in the World Health Organisation's ICD-11, which removed trans identity from its list of mental disorders in 2019. So when a Russian doctor stands at a medical congress and proposes something called "transgender spectrum disorder", they are not doing science. They are doing politics in a white coat.

We have seen this playbook before

The exact same strategy was used to pathologise gay people for decades. Dress the prejudice in clinical language, give it a Latin-sounding name, present it at a conference, and suddenly it looks like medicine. It is not medicine. It is stigma with footnotes.

The WHO delisted homosexuality from its diagnostic manuals in 1990. It took another three decades before trans identity followed. Both decisions came after sustained, evidence-based review, not political lobbying. The people lobbying were, in both cases, the ones trying to keep the diagnosis, not remove it.

That history matters here, because what is being attempted in Russia is a deliberate reversal of that progress, and it is worth being clear-eyed about why.

What 'transgender spectrum disorder' is actually for

A diagnosis of this kind does not exist to help trans people. It exists to give the state, the medical establishment, and the family legal and clinical cover to override a person's self-understanding. If being trans is a disorder, then treating it becomes suppression. Transition becomes contraindicated. A trans person becomes a patient to be corrected rather than a person to be supported.

In the Russian context, this is not a fringe academic curiosity. Russia passed legislation in 2023 banning gender-affirming medical care and legal gender recognition. A revived pathologising diagnosis fits neatly into that legislative architecture: it gives the prohibition a medical rationale and makes trans identity something that can, in principle, be institutionally managed rather than simply lived.

Clinical language does not make something science

One of the most persistent and damaging myths in this area is that if something is proposed at a medical congress, or published in a journal, it carries inherent credibility. It does not. Science is not a venue; it is a method. And the method here, reviving a diagnostic category that the global medical community has rejected, without new evidence, without peer-reviewed data, without any coherent clinical rationale for the harms it would address, is not science.

The WPATH Standards of Care, now in their eighth edition, the Endocrine Society clinical practice guidelines, and the ICD-11 all reflect the same position: gender diversity is a normal part of human variation. Distress, where it exists, comes overwhelmingly from stigma, rejection, and denial of care, not from being trans. The evidence base for gender-affirming care, accumulated over decades, is clear on this. Proposing a new disorder does not undo that evidence; it simply ignores it.

This is not just a Russian story

I want to be direct about something. It would be easy to read this as a story about Russia, with a comfortable implication that it could not happen here. But the same logic, that trans identity is a symptom to be treated rather than an identity to be affirmed, circulates in UK and European policy debates too, sometimes in softened language, sometimes from people who would be offended to be compared to a Russian state medical congress. The vehicle is different. The destination is the same.

The answer is not nuance. The answer is clarity. Trans people are not disordered. Their lives are not a pathology. And any diagnosis constructed to say otherwise is not medicine; it is harm with a letterhead.

If this is useful to you, please share it. Every share helps more people find accurate information about gender diversity.